UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 288

Sortiert nach

Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer

The Journal of clinical investigation, 2023-01, Vol.133 (2), p.1-9

2023

Volltextzugriff (PDF)

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

CA: a cancer journal for clinicians, 2023-11, Vol.73 (6), p.620-652

2023

Volltextzugriff (PDF)

2020 Innovation‐Based Optimism for Lung Cancer Outcomes

The oncologist (Dayton, Ohio), 2021-03, Vol.26 (3), p.e454-e472

2021

Volltextzugriff (PDF)

Personalized one-two punches for lung cancer

Cell research, 2015-03, Vol.25 (3), p.269-270

2015

Volltextzugriff (PDF)

Worldwide overview of the current status of lung cancer diagnosis and treatment

Archives of pathology & laboratory medicine (1976), 2012-12, Vol.136 (12), p.1478-1481

Bunn, Jr, Paul A

2012

Volltextzugriff (PDF)

Randomized Phase II Trial of Erlotinib With and Without Entinostat in Patients With Advanced Non–Small-Cell Lung Cancer Who Progressed on Prior Chemotherapy

Journal of clinical oncology, 2012-06, Vol.30 (18), p.2248-2255

2012

Volltextzugriff (PDF)

New Developments in Neoadjuvant Therapy for Lung Cancer

Oncology (Williston Park, N.Y.), 2019-03, Vol.33 (3), p.101-109

2019

Volltextzugriff (PDF)

Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer

Journal of clinical oncology, 2006-05, Vol.24 (13), p.2038-2043

2006

Volltextzugriff (PDF)

Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2006-11, Vol.24 (31), p.5034-5042

2006

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor in Non–Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on Prognosis

Journal of clinical oncology, 2003-10, Vol.21 (20), p.3798-3807

2003

Volltextzugriff (PDF)

Increased EGFR Gene Copy Number Detected by Fluorescent In Situ Hybridization Predicts Outcome in Non–Small-Cell Lung Cancer Patients Treated With Cetuximab and Chemotherapy

Journal of clinical oncology, 2008-07, Vol.26 (20), p.3351-3357

2008

Volltextzugriff (PDF)

Surgery With or Without Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S9900, an Intergroup, Randomized, Phase III Trial

Journal of clinical oncology, 2010-04, Vol.28 (11), p.1843-1849

2010

Volltextzugriff (PDF)

Longitudinal nucleocapsid antibody testing reveals undocumented SARS-CoV-2 infections in patients with lung cancer

Cancer cell, 2023-11, Vol.41 (11), p.1838-1840

2023

Volltextzugriff (PDF)

Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study

Journal of clinical oncology, 2005-10, Vol.23 (28), p.6838-6845

2005

Volltextzugriff (PDF)

Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non–small cell lung carcinoma

Molecular cancer therapeutics, 2007-06, Vol.6 (6), p.1683-1691

2007

Volltextzugriff (PDF)

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines

Cancer research (Chicago, Ill.), 2006-01, Vol.66 (2), p.944-950

2006

Volltextzugriff (PDF)

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy

Journal of clinical oncology, 2004-05, Vol.22 (9), p.1589-1597

2004

Volltextzugriff (PDF)

Fibroblast Growth Factor (FGF) and FGF Receptor-Mediated Autocrine Signaling in Non-Small-Cell Lung Cancer Cells

Molecular pharmacology, 2009-01, Vol.75 (1), p.196-207

2009

Volltextzugriff (PDF)

International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy

Journal of thoracic oncology, 2023-10, Vol.18 (10), p.1290-1302

2023

Volltextzugriff (PDF)

Insulin-like Growth Factor Receptor 1 (IGF1R) Gene Copy Number Is Associated With Survival in Operable Non–Small-Cell Lung Cancer: A Comparison Between IGF1R Fluorescent In Situ Hybridization, Protein Expression, and mRNA Expression

Journal of clinical oncology, 2010-05, Vol.28 (13), p.2174-2180

2010

Volltextzugriff (PDF)

The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC

Drug design, development and therapy, 2018-01, Vol.12, p.981-986

2018

Volltextzugriff (PDF)

Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer

Cancer cell, 2022-06, Vol.40 (6), p.575-577

2022

Volltextzugriff (PDF)

Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Who, What, When, Why?

Journal of clinical oncology, 2002-09, Vol.20 (suppl 1), p.23s-33s

BUNN, Paul A

2002

Volltextzugriff (PDF)

Increased HER2 Gene Copy Number Is Associated With Response to Gefitinib Therapy in Epidermal Growth Factor Receptor–Positive Non–Small-Cell Lung Cancer Patients

Journal of clinical oncology, 2005-08, Vol.23 (22), p.5007-5018

2005

Volltextzugriff (PDF)

Adjuvant TKIs in NSCLC: what can we learn from RADIANT?

Nature reviews. Clinical oncology, 2015-12, Vol.12 (12), p.689-690

2015

Volltextzugriff (PDF)

1 – 25 von 288

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(281)
Mit Volltextzugriff
(249)

Publikationsform

Artikel
(288)

Sprache

Englisch
(287)
Japanisch
(39)

Erscheinungsjahr

n.n

Thema

Humans
(257)
Science & Technology
(240)
Life Sciences & Biomedicine
(234)
Oncology
(176)
Lung Neoplasms - Drug Therapy
(108)
Female
(105)
Biological And Medical Sciences
(102)
Medical Sciences
(100)
Male
(97)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(87)
Middle Aged
(82)
Lung Neoplasms - Pathology
(74)
Aged
(71)
Adult
(60)
Pneumology
(48)
Tumors Of The Respiratory System And Mediastinum
(48)
Pharmacology. Drug Treatments
(47)
Lung Cancer
(46)
Antineoplastic Agents
(43)
Lung Neoplasms - Genetics
(42)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Clinical Cancer Research
(31)
Journal Of Clinical Oncology
(27)
Journal Of Thoracic Oncology
(22)
Seminars In Oncology
(21)
Cancer Research
(14)
Cancer
(12)
Jnci : Journal Of The National Cancer Institute
(11)
Clinical Lung Cancer
(10)
Chest
(9)
Lung Cancer
(8)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

2020 Innovation‐Based Optimism for Lung Cancer Outcomes

Personalized one-two punches for lung cancer

Worldwide overview of the current status of lung cancer diagnosis and treatment

Randomized Phase II Trial of Erlotinib With and Without Entinostat in Patients With Advanced Non–Small-Cell Lung Cancer Who Progressed on Prior Chemotherapy

New Developments in Neoadjuvant Therapy for Lung Cancer

Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer

Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer

Epidermal Growth Factor Receptor in Non–Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on Prognosis

Increased EGFR Gene Copy Number Detected by Fluorescent In Situ Hybridization Predicts Outcome in Non–Small-Cell Lung Cancer Patients Treated With Cetuximab and Chemotherapy

Surgery With or Without Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S9900, an Intergroup, Randomized, Phase III Trial

Longitudinal nucleocapsid antibody testing reveals undocumented SARS-CoV-2 infections in patients with lung cancer

Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study

Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non–small cell lung carcinoma

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy

Fibroblast Growth Factor (FGF) and FGF Receptor-Mediated Autocrine Signaling in Non-Small-Cell Lung Cancer Cells

International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy

Insulin-like Growth Factor Receptor 1 (IGF1R) Gene Copy Number Is Associated With Survival in Operable Non–Small-Cell Lung Cancer: A Comparison Between IGF1R Fluorescent In Situ Hybridization, Protein Expression, and mRNA Expression

The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC

Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer

Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Who, What, When, Why?

Increased HER2 Gene Copy Number Is Associated With Response to Gefitinib Therapy in Epidermal Growth Factor Receptor–Positive Non–Small-Cell Lung Cancer Patients

Adjuvant TKIs in NSCLC: what can we learn from RADIANT?

Suchergebnisse filtern